{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:45:45Z","timestamp":1786769145544,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1433,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 AI057159"],"award-info":[{"award-number":["U54 AI057159"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1074\/jbc.m116.749184","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:07:33Z","timestamp":1471565253000},"page":"21596-21606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection"],"prefix":"10.1016","volume":"291","author":[{"given":"Catherine E.","family":"Vrentas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Moayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Greaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"O'Mard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.749184_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax pathogenesis","volume":"69","author":"Moayeri","year":"2015","journal-title":"Annu. Rev. Microbiol"},{"key":"10.1074\/jbc.M116.749184_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"10.1074\/jbc.M116.749184_bib3","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1074\/jbc.M114.627943","article-title":"A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model","volume":"290","author":"Moayeri","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.749184_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.M116.749184_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/nnm.13.86","article-title":"Nanobodies and their potential applications","volume":"8","author":"Hassanzadeh-Ghassabeh","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1074\/jbc.M116.749184_bib6","doi-asserted-by":"crossref","first-page":"36538","DOI":"10.1074\/jbc.M113.519207","article-title":"Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin","volume":"288","author":"Vance","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.749184_bib7","doi-asserted-by":"crossref","first-page":"e29941","DOI":"10.1371\/journal.pone.0029941","article-title":"A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model","volume":"7","author":"Mukherjee","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M116.749184_bib8","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/IAI.01033-13","article-title":"A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2","volume":"81","author":"Tremblay","year":"2013","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib9","doi-asserted-by":"crossref","first-page":"27880","DOI":"10.1074\/jbc.M115.658070","article-title":"Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies","volume":"290","author":"Herrera","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.749184_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nsmb.1923","article-title":"Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers","volume":"17","author":"Feld","year":"2010","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.M116.749184_bib11","doi-asserted-by":"crossref","first-page":"e65855","DOI":"10.1371\/journal.pone.0065855","article-title":"Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor","volume":"8","author":"Thullier","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M116.749184_bib12","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/IAI.05314-11","article-title":"Mouse monoclonal antibodies to anthrax edema factor protect against infection","volume":"79","author":"Leysath","year":"2011","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2010.10.004","article-title":"Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice","volume":"8","author":"Liu","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1074\/jbc.M116.749184_bib14","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/AAC.00941-13","article-title":"Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection","volume":"57","author":"Moayeri","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M116.749184_bib15","doi-asserted-by":"crossref","first-page":"e106422","DOI":"10.1371\/journal.pone.0106422","article-title":"Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein","volume":"9","author":"Mukherjee","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M116.749184_bib16","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin","volume":"73","author":"Lim","year":"2005","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.toxicon.2010.07.003","article-title":"Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases","volume":"56","author":"Tremblay","year":"2010","journal-title":"Toxicon"},{"key":"10.1074\/jbc.M116.749184_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2217\/fmb.11.32","article-title":"Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea","volume":"6","author":"Pant","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1074\/jbc.M116.749184_bib19","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M116.749184_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.2014.82","article-title":"Adenoviral targeting using genetically incorporated camelid single variable domains","volume":"94","author":"Kaliberov","year":"2014","journal-title":"Lab. Invest"},{"key":"10.1074\/jbc.M116.749184_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CVI.00611-15","article-title":"Adenoviral expression of a bispecific VHH- based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice","volume":"23","author":"Moayeri","year":"2016","journal-title":"Clin. Vaccine Immunol"},{"key":"10.1074\/jbc.M116.749184_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2016.1185581","article-title":"Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin fv domain: an investigation into the correlation between affinity and serum half-life","author":"Adams","year":"2016","journal-title":"Mabs"},{"key":"10.1074\/jbc.M116.749184_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2012.00159","article-title":"Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins","volume":"2","author":"L\u00f3pez-Requena","year":"2012","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.M116.749184_bib24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/iai.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","article-title":"Optimized production and purification of Bacillus anthracis lethal factor","volume":"18","author":"Park","year":"2000","journal-title":"Protein Expr. Purif"},{"key":"10.1074\/jbc.M116.749184_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/IAI.74.1.682-693.2006","article-title":"Genome engineering in Bacillus anthracis using Cre recombinase","volume":"74","author":"Pomerantsev","year":"2006","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijpara.2007.02.005","article-title":"Three surface antigens dominate the mucosal antibody response to gastrointestinal L3-stage strongylid nematodes in field immune sheep","volume":"37","author":"Maass","year":"2007","journal-title":"Int. J. Parasitol"},{"key":"10.1074\/jbc.M116.749184_bib28","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/IAI.00200-09","article-title":"Novel chimpanzee\/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody","volume":"77","author":"Chen","year":"2009","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M116.749184_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","article-title":"Crystal structure of the anthrax lethal factor","volume":"414","author":"Pannifer","year":"2001","journal-title":"Nature"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820358415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820358415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.749184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:32:00Z","timestamp":1641281520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820358415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0021925820358415"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.749184","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.749184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}